> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Dewpoint Therapeutics
- URL: https://www.whiteroseintelligence.com/dewpoint-therapeutics/
- Published: 1999-01-02T15:15:00.000Z
- Updated: 2025-01-02T05:38:29.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**Dewpoint Therapeutics** is an American biotechnology company based in Boston, Massachusetts.

## COVID-19

Dewpoint participated as an industry partner in the [Accelerating COVID-19 Therapeutic Interventions and Vaccines](https://www.whiteroseintelligence.com/Accelerating-COVID-19-Therapeutic-Interventions-and-Vaccines) (ACTIV) public-private partnership hosted by the Foundation for the National Institutes of Health.[\[1\]](#fn1)

## Organization

| Name        | Position                                 | Notes                                      |
| ----------- | ---------------------------------------- | ------------------------------------------ |
| Kara Carter | Senior Vice President, Discovery Biology | ACTIV Preclinical and TRACE Working Groups |

### Investors

Investors in Dewpoint Therapeutics include:[\[2\]](#fn2)[\[3\]](#fn3)[\[4\]](#fn4)

- 3E Bioventures Capital
- 6 Dimensions Capital
- Alexandria Venture Investments
- ARCH Venture Partners
- Bellco Capital
- EcoR1 Capital
- [General Catalyst](https://www.whiteroseintelligence.com/General-Catalyst)[\[5\]](#fn5)
- Innovation Endeavors
- Leaps by Bayer
- Maverick Ventures
- Mirae Asset Capital
- Mubadala Ventures
- NS Investment
- Polaris Partners
- Samsara BioCapital
- SoftBank Vision Fund[\[6\]](#fn6)

### Partners

Dewpoint is developing products through partnerships with:[\[7\]](#fn7)

- [Bayer](https://www.whiteroseintelligence.com/Bayer)
- [Merck](https://www.whiteroseintelligence.com/Merck)
- Novo Nordisk
- [Pfizer](https://www.whiteroseintelligence.com/Pfizer)

## External links

- [Website](https://dewpointx.com/)

---

1. *ACTIV.* National Institutes of Health (NIH). Retrieved April 1, 2022, from <http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ> [↩︎](#fnref1)
2. *Series A - Dewpoint Therapeutics - 2019-01-30 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved July 3, 2023, from <https://www.crunchbase.com/funding%5Fround/dewpoint-therapeutics-series-a--aac46ca0> [↩︎](#fnref2)
3. *Series B - Dewpoint Therapeutics - 2020-09-29 - Crunchbase Funding Round Profile.* Crunchbase. Retrieved July 3, 2023, from <https://www.crunchbase.com/funding%5Fround/dewpoint-therapeutics-series-b--80fadead> [↩︎](#fnref3)
4. Bressi, J., & Peterson, S. (2022, February 3). *Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing.* Dewpoint Therapeutics. <https://web.archive.org/web/20230703183902/https://dewpointx.com/dewpoint-therapeutics-announces-completion-of-150-million-series-c-financing/> [↩︎](#fnref4)
5. *All Companies.* (2022, October 28). General Catalyst. <http://archive.today/2022.12.03-033447/https://www.generalcatalyst.com/list> [↩︎](#fnref5)
6. *Portfolio.* SoftBank Vision Fund. Retrieved May 5, 2023, from <https://web.archive.org/web/20230505171511/https://visionfund.com/portfolio> [↩︎](#fnref6)
7. *Pipeline.* Dewpoint Therapeutics. Retrieved July 3, 2023, from <http://archive.today/2023.07.03-184111/https://dewpointx.com/pipeline/%23partnerships> [↩︎](#fnref7)